Ads
related to: dcis survival rate
Search results
Results From The WOW.Com Content Network
Ductal carcinoma in situ (DCIS), also known as intraductal carcinoma, is a pre-cancerous or non-invasive cancerous lesion of the breast. [ 1 ] [ 2 ] DCIS is classified as Stage 0. [ 3 ] It rarely produces symptoms or a breast lump that can be felt, typically being detected through screening mammography .
Cases detected by screening have favorable survival compared to cases that present clinically. [12] White women have the highest rate of breast carcinoma, followed by Black, Asian/Pacific Islander, and Hispanic women. However, Black women are most likely to have greater severity of disease and triple-receptor negativity at time of diagnosis.
The overall 5-year survival rate for both invasive ductal carcinoma and invasive lobular carcinoma was approximately 85% in 2003. [9] Ductal carcinoma in situ, on the other hand, is in itself harmless, although if untreated approximately 60% of these low-grade DCIS lesions will become invasive over the course of 40 years in follow-up. [10]
Ductal carcinoma in situ, ... scant evidence that it was actually helping to lower all-cause death rates. ... for 1,000 men screened over 10 years–and no effect on overall survival. ...
The prognosis is very positive since the cancer is at stage 0, meaning treatment will be less invasive and more effective, with a survival rate of 99%, according to the National Breast Cancer ...
Comedocarcinoma is a kind of breast cancer that demonstrates comedonecrosis, which is the central necrosis [1] of cancer cells within involved ducts. Comedocarcinomas are usually non-infiltrating and intraductal tumors, characterized as a comedo-type, high-grade ductal carcinoma in situ (DCIS).
Ads
related to: dcis survival rate